Adalvo: Empowering Global Healthcare with EQT Partnership
Deal News | Jul 18, 2025 | EQT
EQT, a global investment organization, has announced its plans to acquire a majority stake in Adalvo, a leading B2B dossier developer in the pharmaceutical sector. This acquisition is aimed at supporting Adalvo's growth to further its mission of providing affordable healthcare. Adalvo, established in 2018 and headquartered in Malta, partners with over 170 generic companies across 140 countries. The acquisition plan involves EQT investing in R&D, enhancing operational excellence, expanding product portfolios, and extending strategic partnerships to meet the increasing demand for generic drugs. Existing shareholders like Aztiq will remain as minority shareholders. This strategic move reflects EQT's commitment to supporting companies that deliver essential services to society. The completion of the transaction is expected by the second half of 2025, subject to customary regulatory approvals.
Sectors
- Pharmaceutical Industry
- Private Equity
Geography
- Global – Adalvo and EQT operate across multiple regions worldwide, reflecting the global scope of this transaction and partnership.
- Malta – Adalvo is headquartered in Malta, indicating the geographical base of one of the primary entities involved.
Industry
- Pharmaceutical Industry – Adalvo operates in the pharmaceutical industry, focusing on developing and distributing generic drugs across the globe.
- Private Equity – EQT's acquisition of Adalvo involves strategic investment, characteristic of private equity operations.
Financials
- 55-60% – EQT X is expected to be 55-60 percent invested including this transaction.
- 266 billion – Total assets under management by EQT as of 30 June 2025.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| EQT | Buyer | Company | A global investment organization acquiring a majority stake in Adalvo. |
| Adalvo | Target Company | Company | A leading B2B dossier developer focused on providing generic pharmaceutical products. |
| Aztiq | Selling Company | Company | The holding company of Adalvo's current Chair, remaining as a minority shareholder post-transaction. |
| Robert Wessman | Chairman | Person | Chairman of Aztiq and involved in the strategic direction of Adalvo. |
| Anil Okay | CEO | Person | CEO of Adalvo, leading the company's strategic and operational efforts. |